MCM
AZN icon

Mason Capital Management’s AstraZeneca AZN Stock Holding History

Mason Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,345,785
Closed -$249M – 50
2014
Q2 		$249M Buy
+3,345,785
New +$242M 2.96% 11

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Mason Capital Management's AZN Position: Q3 2014 in Review

Mason Capital Management sold out of AstraZeneca (AZN) in Q3 2014, closing a stake of 3,345,785 shares — an estimated $249M sold.

Mason Capital Management first reported a position in AZN in Q2 2014 and held it in 1 quarter. The position peaked at $249M in Q2 2014. 402 funds tracked by Wall St. Rank hold AZN as of Q3 2014.

  • Mason Capital Management reported no remaining AstraZeneca position as of Q3 2014 after selling out during the quarter.
  • Mason Capital Management sold 3,345,785 AstraZeneca shares in Q3 2014, an estimated $249M.
  • Mason Capital Management first reported a position in AstraZeneca in Q2 2014 and held it in 1 quarter.
  • Mason Capital Management's AstraZeneca position peaked at $249M in Q2 2014.
  • 402 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2014.

Based on Mason Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.